HHS Authorizes Pharmacists to Administer Vaccines to Children
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Vaccines
Immunization Schedules: Best Available Evidence for 2020
Review of the Advisory Committee Immunization Practices updates to the pediatric immunization schedule and significant revisions to the adult immunization schedule.
Moderna Charging Much More for COVID-19 Vaccine Than Others
Moderna is charging $37 a dose for its experimental vaccine, which is far more than what other companies say they plan to charge for their vaccines.
Plenty of COVID-19 Vaccine Coming, Fauci Says
When a COVID-19 vaccine is approved, there should be plenty of it available.
Early Data Show Investigational ChAdOx1 nCoV-19 Vaccine Safe, Immunogenic
Interim results from the phase 1/2 COV001 trial evaluating the vaccine candidate ChAdOx1 nCoV-19 (AZD1222) showed that vaccination led to strong immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in all evaluated participants.
COVID-19 Vaccine Initiative May Favor Rich Countries
A global COVID-19 vaccine initiative has been formed with the objective of ensuring fair distribution of vaccines worldwide, but it may benefit rich countries more than poor nations.
Immune Responses Observed in All Participants Dosed With Moderna’s COVID-19 Vaccine Candidate
Participants demonstrated high levels of neutralizing antibody activity that exceeded those seen in convalescent sera obtained from persons with confirmed COVID-19.
Model Estimates Herd Immunity Threshold for COVID-19
A mathematical model shows that SARS-CoV-2 disease-induced herd immunity level may be lower than the classical model assuming homogenous immunization.
Pfizer, BioNTech’s COVID-19 Vaccine Candidate Looks Promising in Early Human Trial
Pfizer and BioNTech SE announced positive preliminary results from the phase 1/2 study evaluating the safety, tolerability, and immunogenicity of escalating doses of the vaccine candidate BNT162b1 against COVID-19.
Post-Vaxx Febrile Seizures Not Linked to Child Development Outcomes
Young children experiencing an initial vaccine-proximate (VP) febrile seizure (FS) do not have increased risk of developmental or behavioral problems.
-
Loading...
-
Loading...
Next post in Medicine
